Clinical Trial Update: The Effects of Nitazoxanide in Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 2 clinical trial evaluating nitazoxanide for hepatic encephalopathy, sponsored by Ain Shams University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Ain Shams University | Conditions: Hepatic Encephalopathy | Phase 2 | Status: UNKNOWN